A Phase II, Randomized, Blinded, Sham Procedure-Controlled, Parallel-Group Trial to Evaluate the Efficacy, Safety and Tolerability of LYR-210 in Adult Subjects with Chronic Sinusitis

Project: Research

Project Description

NMA HREC Ref Number: HREC/2019/QRBW/48228
NMA SSA Ref Number: SSA/48228/MonH-2019-167581(v1)
Monash Health Ref Number: RES-19-0000-171X
StatusActive
Effective start/end date28/03/1927/03/24

Keywords

  • clinical trial
  • phase 2 study
  • treatment efficacy
  • chronic sinusitis
  • clinical trial
  • phase 2 study
  • treatment efficacy
  • chronic sinusitis
  • clinical trial
  • phase 2 study
  • treatment efficacy
  • chronic sinusitis